Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 43
New volume-based criteria from NIH predict cancer survival
By
Erik L. Ridley
Tumor assessment criteria that account for both tumor density and volume more accurately reflect tumor burden, and they may improve treatment monitoring by predicting outcomes earlier than methods that rely only on tumor density, according to research from the U.S. National Institutes of Health (NIH).
June 24, 2014
SNMMI: SPECT/CT shines at sentinel lymph-node imaging
By
AuntMinnie.com staff writers
Presurgical SPECT/CT provides more effective sentinel node imaging than lymphoscintigraphy, according to results from an international multicenter trial presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 9, 2014
SNMMI: New PET tracer detects recurrent prostate cancer
By
Wayne Forrest
ST. LOUIS - German researchers have developed a new PET radiotracer that detects recurrent prostate cancer in patients with very low prostate-specific antigen levels, according to two preliminary studies presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 8, 2014
Prostate cancer rad therapy may cause other cancers
By
AuntMinnie.com staff writers
Men with prostate cancer who receive radiation therapy are more likely to develop bladder or rectal cancer, according to a study presented at this week's American Society of Clinical Oncology meeting.
June 1, 2014
Study: MRI benefits prostate cancer
By
AuntMinnie.com staff writers
Prostate biopsies performed with MRI are more likely to find aggressive tumors than those that rely on ultrasound, according to a study presented this week at the American Urological Association meeting.
May 21, 2014
Start-up firm Blue Earth Diagnostics develops prostate PET agent
By
Wayne Forrest
Researchers from GE Healthcare have set out on their own with Blue Earth Diagnostics, a start-up with plans to commercialize a PET radiopharmaceutical they hope will prove more useful than FDG for detecting and assessing recurrent prostate cancer.
May 1, 2014
ASTRO releases endometrial rad therapy guideline
By
AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) has released a new guideline that details the use of adjuvant radiation therapy in the treatment of endometrial cancer.
April 24, 2014
New PET technique may aid prostate imaging
By
AuntMinnie.com staff writers
Colorado researchers have developed a way to alter lipid metabolism in a cancer cell to make it use more FDG, potentially improving detection with PET.
April 7, 2014
SIR: Prostate artery embolization proves useful
By
Eric Barnes
An emerging treatment known as prostate artery embolization for benign prostatic hyperplasia is effective and long-lasting, without causing sexual dysfunction, according to a study presented at the Society of Interventional Radiology (SIR) annual scientific meeting this week in San Diego.
March 23, 2014
NOPR: NaF-PET can change prostate cancer treatment plans
By
Wayne Forrest
PET imaging with sodium fluoride (NaF) changed treatment in more than half of men with prostate cancer and could prove to be a better tool than bone scintigraphy, according to an analysis from the National Oncologic PET Registry (NOPR) published online February 27 in the
Journal of Nuclear Medicine
.
March 16, 2014
Tread cautiously with MR-guided prostate biopsies
By
Philip Ward
VIENNA - MR-guided biopsies of the prostate should only be performed in select patients, and it's vital to keep aware of false-negative results. Also, an urgent need exists for robust multicenter trials of targeted biopsies of the prostate, ECR 2014 delegates learned during a Special Focus session on Saturday.
March 8, 2014
New model for CKD screening cuts eGFR redundancies in half
By
Rebekah Moan
VIENNA - Because of the proportion of false positives in predicting chronic kidney disease (CKD) in patients undergoing contrast-enhanced CT, the current combination of all risk factors is inaccurate, delegates at ECR 2014 learned. A less elaborate model cuts estimated glomerular filtration rate (eGFR) redundancies by 50%.
March 8, 2014
Previous Page
Page 43 of 93
Next Page